Literature DB >> 28011212

PPARβ in macrophages and atherosclerosis.

G Chinetti-Gbaguidi1, B Staels2.   

Abstract

Macrophages are central cells in the genesis and development of atherosclerosis, one of the major causes of cardiovascular diseases. Macrophages take up lipids (mainly cholesterol and triglycerides) from lipoproteins thus transforming into foam cells. Moreover, through the efflux pathway, macrophages are the main actors of the elimination of excessive tissue cholesterol toward extra-cellular acceptors. Macrophages participate in the control of inflammation by displaying different functional phenotypes, from the M1 pro-inflammatory to the M2 anti-inflammatory state. The nuclear receptor Peroxisome Proliferator-Activated Receptor (PPAR)β (also called PPARδ or PPARβ/δ) is expressed in macrophages where it plays a different role in the control of lipid metabolism, inflammation and phagocytosis of apoptotic cells. This review will summarize our current understanding of how PPARβ regulates macrophage biology and its impact on atherosclerosis. Differences between studies and species-specific macrophage gene regulation will be discussed.
Copyright © 2016 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Atherosclerotic lesion; Gene regulation; Inflammation; Lipid metabolism; Transcription factor

Mesh:

Substances:

Year:  2016        PMID: 28011212     DOI: 10.1016/j.biochi.2016.12.008

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

1.  Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?

Authors:  Joel Grunhut; Wei Wang; Berk Aykut; Inderdeep Gakhal; Alejandro Torres-Hernandez; George Miller
Journal:  Eur Med J Hepatol       Date:  2018-05-31

2.  AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE-/- mice.

Authors:  Ang Ma; Jing Wang; Liu Yang; Yuanyuan An; Haibo Zhu
Journal:  J Lipid Res       Date:  2017-06-13       Impact factor: 5.922

Review 3.  The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review.

Authors:  Yu Liu; Jiayu Wang; Shuangyan Luo; Yi Zhan; Qianjin Lu
Journal:  J Autoimmun       Date:  2020-07-01       Impact factor: 7.094

Review 4.  Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.

Authors:  Chang Wang; Ying Shi; Xiaomei Wang; Heming Ma; Quan Liu; Yanhang Gao; Junqi Niu
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

Review 5.  The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor.

Authors:  Yi Liu; Jennifer K Colby; Xiangsheng Zuo; Jonathan Jaoude; Daoyan Wei; Imad Shureiqi
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

Review 6.  PPARβ/δ: Linking Metabolism to Regeneration.

Authors:  Ajit Magadum; Felix B Engel
Journal:  Int J Mol Sci       Date:  2018-07-10       Impact factor: 5.923

Review 7.  Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis.

Authors:  Béla Kovács; Enikő Vajda; Előd Ernő Nagy
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

8.  Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages.

Authors:  Yuxian Guo; Yaru Liu; Shihao Zhao; Wangting Xu; Yiqing Li; Pengwei Zhao; Di Wang; Hongqiang Cheng; Yuehai Ke; Xue Zhang
Journal:  Nat Commun       Date:  2021-12-07       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.